News
Carduso portfolio company VRelax wins prestigious ‘Prix Galien MedTech Innovation Award’ 2021
2021-05-20 08:35:34 / Latest news
Carduso Capital invests in start-up Notoxins that develops an innovative remedy for excessive sweating.
2020-06-10 14:10:38 / Latest news
Carduso en RHM invests in Groningen start-up QDI-Systems ‘Quantum Dots’: the next generation in X-ray technology.
2020-06-08 12:34:22 / Latest news
Carduso Capital invests in Groningen startup Ivy Medical to develop a wearable “next generation” infusion pump.
2020-06-05 14:24:05 / Latest news
Carduso Capital finances the Groningen ViroTact that is developing a rapid, point of care COVID-19 test for the immediate detection of Corona contamination.
2020-05-06 17:41:36 / Latest news
VRelax combats the consequences of Covid-19 by reducing stress with Virtual Reality.
2020-04-22 11:14:34 / Latest news
Carduso Capital invests in BUKU: “Making study books available to everyone, worldwide” one step closer
2020-03-06 11:00:18 / Latest news
Carduso Capital investeert in BUKU; de Groningse Start-Up dat een streaming-platform heeft ontwikkeld voor het beschikbaar stellen van studieboeken in het hoger onderwijs.
PIMS-E:
2019-04-26 09:48:06 / Latest news
Develops an alternative for the currently used invasive self-treatment by injection, when a life-threatening situation in case of a severe allergic reaction occurs.
Carduso Capital participation ‘BioBTX’ and Teijin Aramid are looking at sustainable feedstock for super fiber.
2018-10-30 11:06:31 / Latest news
Carduso participation Deam receives innovation award from Mona Keijzer, state secretary for economic affairs.
2018-10-24 07:55:26 / Latest news
BioBTX commences operation of pilot plant for production of sustainable platform chemicals
2018-09-13 08:00:16 / Latest news
Carduso Capital invests in “CC Diagnostics”
2018-07-17 09:40:49 / Latest news
Carduso Capital invests in the Groningen start-up CC Diagnostics that is developing an unique test kit for detection of early stage cervical cancer. Cervical cancer is a worldwide problem, but in population-based screening programs the incidence of cervical cancers has decreased significantly in the last decades. With regular screening, the early precancerous changes in cervical cells can be detected and treated, and consequently preventing the development of cervical cancer.
BiOrion Technologies receives an EFRO TENDER VALORISATIE 2017 grant for its € 1.0 million cardiac fibrosis imaging program.
2018-01-18 13:27:51 / Latest news
Request financing